Rallybio Corp (Nasdaq:RLYB)
Health Care/Life Sciences • Pharmaceuticals
CIK 1739410
Company
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.
Address
234 Church Street
Suite 1020
New Haven, Connecticut 06510
234 Church Street
Suite 1020
New Haven, Connecticut 06510
Employees
41
41
Stock Info
Close
$1.8550
$1.8550
Day Range
1.8400 - 2.1599
1.8400 - 2.1599
52 Week Range
1.2250 - 9.1400
1.2250 - 9.1400
Average volume
236.74K
236.74K
Short Interest
1.08M (02/15/24)
1.08M (02/15/24)
% of Float Shorted
6.26%
6.26%
Market Cap
$74.45M
$74.45M
Revenue
N/A
N/A
Net Income
-$66.65M
-$66.65M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Executive Chairman Martin W MacKay PhD |
President, Chief Executive Officer & Director Stephen Uden MD |
Director Christine A Nash MBA |
Director Liu Hui PhD, MBA |
Director Wendy K Chung MD, PhD |
Independent Director Helen Marie Boudreau MBA |
Independent Director Robert L Hopfner PhD, MBA |
Independent Director Ronald M Hunt MBA |
Independent Director Lucian Iancovici MD |
Independent Director Kush M Parmar MD, PhD |
Independent Director Paula Soteropoulos |
SEC filings
Date | Form | Event |
---|---|---|
8 Aug, 2024 | 8-K | |
8 Aug, 2024 | 10-Q | |
30 Jul, 2024 | SC 13G/A | |
30 Jul, 2024 | SC 13G | |
23 Jul, 2024 | 8-K | |
21 May, 2024 | 8-K | |
20 May, 2024 | EFFECT | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
17 May, 2024 | 4 | |
16 May, 2024 | CORRESP | |
16 May, 2024 | UPLOAD | |
10 May, 2024 | S-3 | |
9 May, 2024 | 8-K | |
9 May, 2024 | 10-Q | |
22 Apr, 2024 | D | |
11 Apr, 2024 | DEF 14A | |
10 Apr, 2024 | 8-K | |
13 Mar, 2024 | S-8 | |
12 Mar, 2024 | 8-K | |
12 Mar, 2024 | 10-K | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
14 Feb, 2024 | SC 13G/A | |
12 Feb, 2024 | SC 13D/A | |
9 Feb, 2024 | SC 13G/A | |
6 Feb, 2024 | 8-K | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
2 Jan, 2024 | SC 13G/A | |
20 Dec, 2023 | 8-K | |
9 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
8 Aug, 2023 | 10-Q | |
8 Aug, 2023 | 8-K | |
29 Jun, 2023 | 8-K | CEO Change |
22 May, 2023 | 8-K | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
12 May, 2023 | 424B3 | |
12 May, 2023 | EFFECT | |
11 May, 2023 | CORRESP | |
11 May, 2023 | UPLOAD | |
10 May, 2023 | S-8 | |
9 May, 2023 | S-3 | |
9 May, 2023 | 10-Q | |
9 May, 2023 | 8-K | |
10 Apr, 2023 | DEF 14A | |
16 Mar, 2023 | 4 | |
9 Mar, 2023 | 4 | |
9 Mar, 2023 | 4 | |
6 Mar, 2023 | 8-K | |
6 Mar, 2023 | 10-K | |
9 Feb, 2023 | SC 13G/A | |
6 Feb, 2023 | 4 | |
6 Feb, 2023 | 4 | |
6 Feb, 2023 | SC 13G/A | |
6 Feb, 2023 | 4 | |
1 Feb, 2023 | 3 | |
1 Feb, 2023 | 4 | |
1 Feb, 2023 | SC 13G/A | |
31 Jan, 2023 | 8-K | |
23 Jan, 2023 | SC 13G/A | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
1 Dec, 2022 | 8-K | |
17 Nov, 2022 | SC 13G | |
17 Nov, 2022 | 4 | |
14 Nov, 2022 | 8-K | |
14 Nov, 2022 | 424B5 | |
10 Nov, 2022 | 424B5 | |
7 Nov, 2022 | 10-Q | |
7 Nov, 2022 | 8-K | |
28 Sep, 2022 | 8-K | |
15 Aug, 2022 | 424B5 | |
15 Aug, 2022 | EFFECT | |
11 Aug, 2022 | UPLOAD | |
11 Aug, 2022 | CORRESP | |
8 Aug, 2022 | 8-K | |
8 Aug, 2022 | 10-Q | |
8 Aug, 2022 | S-3 | |
3 Aug, 2022 | 4 | |
3 Aug, 2022 | 3 | |
2 Aug, 2022 | 8-K | |
7 Jun, 2022 | 4 | |
7 Jun, 2022 | 4 | |
7 Jun, 2022 | SC 13D/A | |
6 Jun, 2022 | S-8 | |
2 Jun, 2022 | 8-K | |
27 May, 2022 | 8-K | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
26 May, 2022 | 4 | |
25 May, 2022 | 4 | |
25 May, 2022 | 4 | |
10 May, 2022 | 10-Q | |
10 May, 2022 | 8-K | |
25 Apr, 2022 | DEF 14A | |
6 Apr, 2022 | 3 | |
6 Apr, 2022 | 4 | |
6 Apr, 2022 | 4 | |
6 Apr, 2022 | 3 | |
4 Apr, 2022 | 8-K | |
23 Mar, 2022 | 4 | |
15 Mar, 2022 | 10-K | |
15 Mar, 2022 | 8-K | |
7 Mar, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G | |
10 Feb, 2022 | 4 | |
10 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
8 Feb, 2022 | SC 13G | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | SC 13G | |
18 Jan, 2022 | SC 13D/A | |
14 Jan, 2022 | 4 | |
12 Jan, 2022 | 4 | |
11 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
10 Nov, 2021 | 8-K | |
10 Nov, 2021 | 10-Q | |
9 Sep, 2021 | 10-Q | |
9 Sep, 2021 | 8-K | |
12 Aug, 2021 | SC 13D | |
12 Aug, 2021 | SC 13D | |
12 Aug, 2021 | SC 13D | |
9 Aug, 2021 | SC 13G | |
4 Aug, 2021 | 3/A | |
4 Aug, 2021 | SC 13G | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
4 Aug, 2021 | 4 | |
2 Aug, 2021 | S-8 | |
2 Aug, 2021 | 4 | |
2 Aug, 2021 | 8-K | |
30 Jul, 2021 | 424B4 | IPO completed |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | 3 | |
29 Jul, 2021 | CERT | |
29 Jul, 2021 | 8-A12B | |
28 Jul, 2021 | EFFECT | |
28 Jul, 2021 | SEC STAFF | |
28 Jul, 2021 | S-1MEF | |
26 Jul, 2021 | CORRESP | |
26 Jul, 2021 | CORRESP | |
22 Jul, 2021 | S-1/A | |
12 Jul, 2021 | CORRESP | |
2 Jul, 2021 | S-1 | |
7 Jun, 2021 | DRSLTR | |
7 Jun, 2021 | DRS/A | |
24 May, 2021 | UPLOAD | |
13 May, 2021 | SEC STAFF | |
27 Apr, 2021 | DRS |
Last update:2024-03-06 13:23:36.272590
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.